CN102600278A - Chinese medicament for treating uterine fibroid - Google Patents
Chinese medicament for treating uterine fibroid Download PDFInfo
- Publication number
- CN102600278A CN102600278A CN2012100637167A CN201210063716A CN102600278A CN 102600278 A CN102600278 A CN 102600278A CN 2012100637167 A CN2012100637167 A CN 2012100637167A CN 201210063716 A CN201210063716 A CN 201210063716A CN 102600278 A CN102600278 A CN 102600278A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese
- herba
- chinese medicament
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of Chinese medicaments and in particular relates to a Chinese medicament for treating uterine fibroid. The Chinese medicament consists of the following bulk pharmaceutical chemicals by weight: 30g of lithospermum, 35g of oldenlandia diffusa, 30g of selfheal, 15g of eclipta alba, 30g of raw oyster, 20g of glossy privet fruit, 15g of circium japonicum, 15g of common cephalanoplos herb, and 20g of Chinese sage herb. The Chinese medicament has the advantages of low price, convenience in use and short treatment period; and the total effective rate is 95.2 percent, and the cure rate is 61.9 percent.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of Chinese medicine of treating hysteromyoma.
Background technology
Doctor trained in Western medicine is thought: the reason that hysteromyoma takes place is relevant with estrogenic stimulation.The traditional Chinese medical science thinks that hysteromyoma forms because of internal injury caused by excess of seven emotions, visceral dysfunction, qi depression to blood stasis.Modern medicine study is found: the normal myometrial tissue of the estrogen receptor amount in the muscular tumor tissue is many.The generation of hysteromyoma causes the endocrine disturbance relevant with secular estrogen content is too high.Hormone metabolism is simultaneously regulated and control by higher nervous center, so the nerve centre activity is to promoting that primary disease also possibly play a part very important.
Modern pharmacology research thinks that blood circulation promoting and blood stasis dispelling can play the effect of expansion and adjustment to uterine smooth muscle, can promote the fibrosis organization softening to absorb with recovering, and can adjust some endocrine disturbance, to the primary disease good effect.
Summary of the invention
The present invention is directed to the prior art deficiency, provide a kind of evident in efficacy, and the Chinese medicine decoction of the treatment hysteromyoma that has no side effect.
Technical scheme of the present invention is: a kind of Chinese medicine of treating hysteromyoma is characterized in that it is made up of the following raw materials in weight medicine: Radix Arnebiae (Radix Lithospermi) 30 grams, Herba Hedyotidis Diffusae 35 grams, Spica Prunellae 30 grams, Herba Ecliptae 15 grams, Concha Ostreae 30 grams, Fructus Ligustri Lucidi 20 grams, Radix Cirsii Japonici 15 grams, Herba Cirsii 15 grams, Herba Salviae Chinensis 20 grams.
Pharmacology analysis: the Radix Arnebiae (Radix Lithospermi) in side's medicine of the present invention has the effect of clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, detoxifcation rash; Herba Hedyotidis Diffusae has the effect of heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation and stopping pain; Spica Prunellae has the effect of liver heat removing and eyesight improving, clearing away heat and promoting diuresis, mass dissipating and swelling eliminating; Herba Ecliptae has the effect of liver-nourishing kidney-boosting, cooling blood for hemostasis; Concha Ostreae has tranquillization with heavy prescription, the YANG hyperactivity suppressing nourishing YIN, and hard masses softening and resolving is restrained astringent or styptic treatment for spontaneous sweating effect; Fructus Ligustri Lucidi has the merit that nourishing the liver and kidney, tonifying YIN nourish blood; Radix Cirsii Japonici is used for cooling blood for hemostasis, clots absorbing detumescence; Herba Cirsii has cooling blood for hemostasis, removing blood stasis to reduce swelling effect; Herba Salviae Chinensis blood circulation promoting and blood stasis dispelling, clearing away heat-damp and promoting diuresis, mass dissipating and swelling eliminating.More than all medicines share, liver-nourishing kidney-boosting is arranged, blood circulation promoting and blood stasis dispelling, the merit of hard masses softening and resolving.
Preparation and instructions of taking: Chinese herbal medicine is put into marmite according to above-mentioned weight, add cold water and soaked 1 hour, boil with high heat earlier, change 30-40 at a simmer minute again, 150ml takes concoction; Add hot water again, change 30 minutes at a simmer after boiling with high heat, the 150ml that takes concoction, with fry in shallow oil for twice medicinal liquid mix after at twice, early, after the supper each with decoction being taken warmly 150ml decoction.
The present invention is cheap, and is easy to use, and treatment time is short, total effective rate 95.2%, cure rate 61.9%.
The specific embodiment:
Embodiment 1: a kind of Chinese medicine of treating hysteromyoma, it is made up of the following raw materials in weight medicine: Radix Arnebiae (Radix Lithospermi) 30 grams, Herba Hedyotidis Diffusae 35 grams, Spica Prunellae 30 grams, Herba Ecliptae 15 grams, Concha Ostreae 30 grams, Fructus Ligustri Lucidi 20 grams, Radix Cirsii Japonici 15 grams, Herba Cirsii 15 grams, Herba Salviae Chinensis 20 grams.
Clinical efficacy of the present invention is summed up:
One, physical data: the present invention uses for many years clinically, and 42 routine patients take, age 28-35 year 20 examples, 35-45 year 22 examples.7 * 6.8 * 6.3cm that hysteromyoma is maximum, 1.1 * 0.8 minimum * 0.7cm.
Two, diagnosis:
1, gynecologial examination is made a definite diagnosis.
2, make a definite diagnosis with ultrasound diagnosis.
Three, boil medicine, method of administration and consumption.
Medicinal cold water soak was put into marmite with Chinese herbal medicine according to above-mentioned weight after 1 hour in of the present invention, added cold water and soaked 1 hour, boiled with high heat earlier, changed 30-40 at a simmer minute again, and 150ml takes concoction; Add hot water again, change 30 minutes at a simmer after boiling with high heat, the 150ml that takes concoction, with fry in shallow oil for twice medicinal liquid mix after at twice, early, after the supper each with decoction being taken warmly 150ml decoction.
Be 1 course of treatment generally, take medicine two courses of treatment of minimum person, at most four courses of treatment of persons with 30 days.
Four, curative effect determinate standard:
Recovery from illness case: make a definite diagnosis the muscular tumor complete obiteration through B ultrasonic and gynecologial examination.
Produce effects case: make a definite diagnosis muscular tumor through B ultrasonic and gynecologial examination and dwindle more than the 1.5cm.
Effective case: make a definite diagnosis muscular tumor through B ultrasonic and gynecologial examination and dwindle below the 1.5cm.
Invalid case: make a definite diagnosis muscular tumor size no change or increase through B ultrasonic and gynecologial examination.
Five, therapeutic effect:
Take this Chinese medicine with the statistical number that is as the criterion 3 courses of treatment, recovery from illness case 26, cure rate 61.9%, produce effects case 10 obvious effective rates 23.8%, effective case 4 effective percentage 9.5%, invalid case 2 invalid 4.8%.
Six, model case:
Case 1: high * *, 30 years old, routine physical examination in August, 2005,2 of hysteromyoma, 1.2 * 0.8 big * 0.6cm, 1.1 * 0.7 little * 0.8cm are found in ultrasound diagnosis.Begin to take Chinese medicine decoction of the present invention, take a course of treatment after, carry out ultrasound diagnosis, fleshy polyp disappears.For preventing recurrence, continue again to take and consolidate curative effect a course of treatment.Follow up a case by regular visits to not recurrence so far.
Case 2: in * *, 40 years old, first visit in November, 2007, the patient makes a definite diagnosis intramural myoma, tumor body 6 * 5.3 * 4.8cm in third-class first class hospital the year before.Take Ramulus Cinnamomi Poria ball electuary a period of time, effect is bad.So take Chinese medicine decoction of the present invention.After the course of treatment, ultrasound diagnosis tumor body 5 * 4.2 * 3.6cm, effect is remarkable.Patient's confidence heightens, continues again to take medicine 2 courses of treatment, and ultrasound diagnosis, muscular tumor disappears.
Claims (1)
1. Chinese medicine of treating hysteromyoma is characterized in that it is made up of the following raw materials in weight medicine: Radix Arnebiae (Radix Lithospermi) 30 grams, Herba Hedyotidis Diffusae 35 grams, Spica Prunellae 30 grams, Herba Ecliptae 15 grams, Concha Ostreae 30 grams, Fructus Ligustri Lucidi 20 grams, Radix Cirsii Japonici 15 grams, Herba Cirsii 15 grams, Herba Salviae Chinensis 20 grams.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100637167A CN102600278A (en) | 2012-03-05 | 2012-03-05 | Chinese medicament for treating uterine fibroid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100637167A CN102600278A (en) | 2012-03-05 | 2012-03-05 | Chinese medicament for treating uterine fibroid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102600278A true CN102600278A (en) | 2012-07-25 |
Family
ID=46518297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100637167A Pending CN102600278A (en) | 2012-03-05 | 2012-03-05 | Chinese medicament for treating uterine fibroid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102600278A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103285172A (en) * | 2013-05-24 | 2013-09-11 | 上海市中医医院 | Chinese medicament composition for treating myoma of uterus and endometrial cancer and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1689615A (en) * | 2004-04-21 | 2005-11-02 | 范崔生 | Bleeding arresting Chinese medicinal composition and its preparation method |
CN1899367A (en) * | 2005-07-19 | 2007-01-24 | 中国中医研究院中药研究所 | Carpet bugle extract, its preparing method, use and composite preparation |
CN101129851A (en) * | 2007-09-24 | 2008-02-27 | 北京艺信堂医药研究所 | Traditional Chinese medicine composition for treating hysteromyoma |
CN101590186A (en) * | 2009-06-29 | 2009-12-02 | 吴清玲 | A kind of Chinese medicine composition of thorough elimination hysteromyoma |
WO2010035262A2 (en) * | 2008-09-25 | 2010-04-01 | Life Biotech Medical Research Ltd | Herbal formulations |
EP2353604A1 (en) * | 2010-02-03 | 2011-08-10 | Jong Hyun Nam | Pharmaceutical composition and health food comprising rhodiola sachalinensis and oldenlandia diffusa for preventing and treating cancer |
-
2012
- 2012-03-05 CN CN2012100637167A patent/CN102600278A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1689615A (en) * | 2004-04-21 | 2005-11-02 | 范崔生 | Bleeding arresting Chinese medicinal composition and its preparation method |
CN1899367A (en) * | 2005-07-19 | 2007-01-24 | 中国中医研究院中药研究所 | Carpet bugle extract, its preparing method, use and composite preparation |
CN101129851A (en) * | 2007-09-24 | 2008-02-27 | 北京艺信堂医药研究所 | Traditional Chinese medicine composition for treating hysteromyoma |
WO2010035262A2 (en) * | 2008-09-25 | 2010-04-01 | Life Biotech Medical Research Ltd | Herbal formulations |
CN101590186A (en) * | 2009-06-29 | 2009-12-02 | 吴清玲 | A kind of Chinese medicine composition of thorough elimination hysteromyoma |
EP2353604A1 (en) * | 2010-02-03 | 2011-08-10 | Jong Hyun Nam | Pharmaceutical composition and health food comprising rhodiola sachalinensis and oldenlandia diffusa for preventing and treating cancer |
Non-Patent Citations (1)
Title |
---|
吴文菊: "紫草消瘤断经汤治疗围绝经期子宫肌瘤52 例", 《浙江临床医学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103285172A (en) * | 2013-05-24 | 2013-09-11 | 上海市中医医院 | Chinese medicament composition for treating myoma of uterus and endometrial cancer and application thereof |
CN103285172B (en) * | 2013-05-24 | 2014-06-25 | 上海市中医医院 | Chinese medicament composition for treating myoma of uterus and endometrial cancer and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103463587B (en) | A kind of Chinese medicine composition for the treatment of Deficiency and coldness of spleen and stomach | |
CN101204481A (en) | Chinese traditional medicine for chronic nephritis | |
CN102784234B (en) | Traditional Chinese medicine composition for treating chronic urticaria | |
CN103340942B (en) | Traditional Chinese medicine composition for treating cervical spondylosis and lumbar spondylosis and preparation method thereof | |
CN103394030B (en) | Traditional Chinese medicine composition for treating depressed liver and deficient spleen | |
CN104666658A (en) | Traditional Chinese medicine composition for treating osteosarcoma ostalgia and bone metastasis neoplasm ostalgia, and preparation method and application of traditional Chinese medicine composition | |
CN102512647B (en) | Chinese herbal composition for treating abdominal pain due to deficiency-cold | |
CN101804108B (en) | Traditional Chinese medicine composition for treating neurogenic headache | |
CN104288303A (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
CN104352725A (en) | Traditional Chinese medicinal composition for treating Parkinson's disease | |
CN103028089A (en) | Traditional Chinese medicine composition for treating waist pains of middle-aged and old people | |
CN103585596B (en) | Traditional Chinese medicine composition for treating migraine | |
CN102600278A (en) | Chinese medicament for treating uterine fibroid | |
CN102846741B (en) | Navel-applied plaster for treating sequelae of hemiplegia and preparation method thereof | |
CN101708324B (en) | Plaster used for treating femoral head necrosis and preparation method thereof | |
CN104784417A (en) | Traditional Chinese medicine composition for curing impotentia | |
CN102626507A (en) | Traditional Chinese medicine for curing uterine fibroid | |
CN103961490A (en) | Compound medicine for treating wind-cold-dampness arthralgia and preparation method thereof | |
CN108079073A (en) | It is a kind of steep pedicure tremble with fear foot alleviate medicine Chinese medicine powder | |
CN102641348B (en) | Collateral-dredging and pain-relieving powder and preparation method thereof | |
CN102579946A (en) | Traditional Chinese medicine for treating postconcussion syndrome | |
CN101219202A (en) | Soup for strengthening tendon and waist | |
CN106214870A (en) | A kind of lavipeditum powder treating rheumatic arthritis and preparation method thereof | |
CN101810785B (en) | Plaster for treating cervical spondylosis | |
CN104524528A (en) | Chinese herb preparation treating anemofrigid-damp arthralgia syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120725 |